AKT1 and cancer: As the elevated EGFR, PI3K/Akt, and NF-kB activation is considered for the possible causes of developing chemoresistance/docetaxel resistance in cancer cells so USP8 silencing might also be a thinkable way to overcome docetaxel resistance for PCa.